IL6 and non-small cell lung carcinoma: High levels of IL-6 are associated withincreased lung cancer.13 Elevated IL-6levels were associated with worse overall survival (OS) at 6, 12,and 24 months.14 Further research on IL-6in independent cohorts could establish its role as a prognostic markerfor NSCLC.